PMC:7463108 / 24953-25277
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T197 | 209-218 | Body_part | denotes | cytokines | http://purl.org/sig/ont/fma/fma84050 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T68 | 0-17 | Disease | denotes | Neuroinflammation | http://purl.obolibrary.org/obo/MONDO_0004466 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T240 | 284-289 | http://purl.obolibrary.org/obo/CLO_0007836 | denotes | Mouse |
T241 | 299-304 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | males |
T242 | 299-304 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | males |
T243 | 319-323 | http://purl.obolibrary.org/obo/CLO_0001185 | denotes | 2018 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T183 | 19-27 | Chemical | denotes | morphine | http://purl.obolibrary.org/obo/CHEBI_17303|http://purl.obolibrary.org/obo/CHEBI_58097 |
T185 | 96-104 | Chemical | denotes | Morphine | http://purl.obolibrary.org/obo/CHEBI_17303 |
T186 | 201-204 | Chemical | denotes | CPP | http://purl.obolibrary.org/obo/CHEBI_34603 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
586 | 85-89 | Gene | denotes | Tat1 | Gene:72472 |
587 | 270-274 | Gene | denotes | CCR5 | Gene:12774 |
588 | 291-294 | Gene | denotes | Tat | Gene:234724 |
662 | 284-289 | Species | denotes | Mouse | Tax:10090 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T378 | 0-196 | Sentence | denotes | Neuroinflammation; morphine tolerance (antinociception), physical withdrawal, reward Tat1–86 No Morphine (75 mg pellet, 5 days) • ↑ Tolerance (↓ anti-nociceptive potency and ↓ withdrawal symptoms) |
T379 | 197-242 | Sentence | denotes | • ↑ CPP and cytokines (24 h after withdrawal) |
T380 | 243-318 | Sentence | denotes | • Above effects reduced by CCR5 blockade Mouse, Tat tg, males (Gonek et al. |
T381 | 319-324 | Sentence | denotes | 2018) |